Icon

EMEND (nda021549)- (40MG,80MG,125MG)

APREPITANT MERCK
40MG,80MG,125MG
Yes No
2027-Sep-26 Expired
None None
None No
EMEND ® is a substance P/neurokinin 1 (NK1) receptor antagonist. EMEND capsules is indicated • in combination with other antiemetic agents, in patients 12 years of age and older for prevention of: o acute and delayed nausea and vomiting associated with initial and repeat courses of highly emetogenic cancer chemotherapy (HEC) including high-dose cisplatin o nausea and vomiting associated with initial and repeat courses of moderately emetogenic cancer chemotherapy (MEC)
3 0 3
Total Other Developers 3
Drugs with Suitability No
40MG ** ** - - 3
80MG ** ** - - 3
125MG ** ** - - 2
NDA Sales Available Total Generic Sales Available
Yes 3
ANDA No Generic Co Manufacturer Name Operations Manufacturer Address Country
****** ****** *** *.*. *********** ********** ***** **, *********, - ****, ******** (***) ***
****** ******** ****** ******** *************** ******* *********** **** **. *, *****-*, ****** **** *** *********, ****, ****** ******* ******, ***** (***) ***
****** ******* ********** ************* *.*. *********** ********** **** ***** ****** **********, ***** ** *, *****, *****, ****** (***) ***

Download GenUS Drug Report


Download GenUS Detailed Report


To get detailed report Contact Us

GenUs Advanced Search





Expired
to
Expired
to


Please contact contact@researchdelta.com to get more details.